19
|
121
|
7rr0B |
Sars-cov-2 receptor binding domain bound to fab pdi 222 |
32
|
194
|
7rr0A |
Sars-cov-2 receptor binding domain bound to fab pdi 222 |
18
|
107
|
7rr0C |
Sars-cov-2 receptor binding domain bound to fab pdi 222 |
44
|
196
|
7oaoEEE |
Nanobody c5 bound to rbd |
47
|
194
|
7oauAAA |
Nanobody c5 bound to kent variant rbd (n501y) |
34
|
125
|
7oayBBB |
Nanobody f2 bound to rbd |
32
|
122
|
7oauBBB |
Nanobody c5 bound to kent variant rbd (n501y) |
42
|
198
|
7oayAAA |
Nanobody f2 bound to rbd |
32
|
121
|
7oaoFFF |
Nanobody c5 bound to rbd |
49
|
219
|
7mzfH |
Sars-cov-2 receptor binding domain bound to fab pdi 37 |
42
|
196
|
7mzfA |
Sars-cov-2 receptor binding domain bound to fab pdi 37 |
48
|
214
|
7mzfL |
Sars-cov-2 receptor binding domain bound to fab pdi 37 |
46
|
214
|
7mznL |
Sars-cov-2 receptor binding domain bound to fab pdi 231 |
47
|
216
|
7n4jL |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2173. |
42
|
226
|
7mznH |
Sars-cov-2 receptor binding domain bound to fab pdi 231 |
35
|
197
|
7mzlA |
Sars-cov-2 receptor binding domain bound to fab pdi 210 |
44
|
202
|
7n4jA |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2173. |
41
|
212
|
7mzlL |
Sars-cov-2 receptor binding domain bound to fab pdi 210 |
49
|
219
|
7n3iH |
Crystal structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment c098 |
50
|
213
|
7n3iL |
Crystal structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment c098 |
29
|
220
|
7mzlH |
Sars-cov-2 receptor binding domain bound to fab pdi 210 |
36
|
197
|
7mznA |
Sars-cov-2 receptor binding domain bound to fab pdi 231 |
45
|
234
|
7n4jH |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing human antibody wrair-2173. |
46
|
216
|
7mzhB |
Sars-cov-2 receptor binding domain bound to fab wcsl 119 |
42
|
198
|
7mzhA |
Sars-cov-2 receptor binding domain bound to fab wcsl 119 |
45
|
216
|
7mzhC |
Sars-cov-2 receptor binding domain bound to fab wcsl 119 |
20
|
213
|
7mlzL |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
20
|
222
|
7mlzH |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
13
|
119
|
7me7A |
Cryoem structure of sars-cov-2 rbd in complex with nanobodies nb17 and nb105 |
25
|
194
|
7me7R |
Cryoem structure of sars-cov-2 rbd in complex with nanobodies nb17 and nb105 |
7
|
124
|
7me7B |
Cryoem structure of sars-cov-2 rbd in complex with nanobodies nb17 and nb105 |
36
|
224
|
7lq7C |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies cv503 and cova1-16 |
38
|
232
|
7lq7P |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies cv503 and cova1-16 |
37
|
214
|
7lq7D |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies cv503 and cova1-16 |
25
|
118
|
7km5C |
Crystal structure of sars-cov-2 rbd complexed with nanosota-1 |
33
|
194
|
7km5A |
Crystal structure of sars-cov-2 rbd complexed with nanosota-1 |
41
|
194
|
7kn3A |
Crystal structure of sars-cov-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody s-b8 fab |
45
|
219
|
7kn3H |
Crystal structure of sars-cov-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody s-b8 fab |
34
|
221
|
7kn4H |
Crystal structure of sars-cov-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody s-e6 fab |
43
|
211
|
7kn4L |
Crystal structure of sars-cov-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody s-e6 fab |
49
|
221
|
7kn3L |
Crystal structure of sars-cov-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody s-b8 fab |
37
|
195
|
7kn4A |
Crystal structure of sars-cov-2 spike protein receptor-binding domain complexed with a pre-pandemic antibody s-e6 fab |
32
|
195
|
7k9kA |
Sars-cov-2 spike rbd in complex with neutralizing fab 2h04 (local refinement) |
15
|
106
|
7k9kL |
Sars-cov-2 spike rbd in complex with neutralizing fab 2h04 (local refinement) |
17
|
121
|
7k9kH |
Sars-cov-2 spike rbd in complex with neutralizing fab 2h04 (local refinement) |
14
|
109
|
7k9iL |
Sars-cov-2 spike rbd in complex with neutralizing fab 2b04 (local refinement) |
20
|
119
|
7k9iH |
Sars-cov-2 spike rbd in complex with neutralizing fab 2b04 (local refinement) |
33
|
195
|
7k9iA |
Sars-cov-2 spike rbd in complex with neutralizing fab 2b04 (local refinement) |
39
|
195
|
7lq7A |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies cv503 and cova1-16 |
45
|
213
|
7lq7Q |
Crystal structure of sars-cov-2 receptor binding domain in complex with antibodies cv503 and cova1-16 |